Filter By Category
Archives
Share on -
EFAVALEUKIN ALFA
Generic Name: EFAVALEUKIN ALFA
ABSTRACT -
Efavaleukin alfa is an engineered interleukin-2 pathway biologic designed to modulate immune responses. It is a protein therapeutic with no small-molecule bond-line structure.
DOSAGE -
SC/IV dosing is protocol-specific and may require careful titration and immune monitoring.
SIDE EEFECTS -
- Injection-site reaction
- Fever, chills, or flu-like symptoms
- Fatigue
- Eosinophilia or lymphocyte changes
- Rash or pruritus
ALLERGIC REACTIONS -
These symptoms may indicate an allergic reaction and require medical attention.
- Hypersensitivity to protein or excipients
- Urticaria, bronchospasm, hypotension, angioedema, or anaphylaxis
DRUG INTEACTIONS-
- Other immunotherapies may increase immune-mediated toxicity
- Immunosuppressants may reduce effect
- Live vaccines require review
PREAUTONS–
- Monitor CBC with differential, liver tests, autoimmune symptoms, and infection signs
- Use caution in active autoimmune disease
- Pregnancy risk requires protocol review
WARNINGS –
- Serious immune activation, cytokine effects, and hypersensitivity are possible
Share on -
. Developed by